• Events
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login
Menu
  • Events
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login
  • August 25, 2021
  • Author: EURETINA

Prize Papers 9: AMD III

This session will take place on 10th September at 13:00 CEST.
 
Chairperson(s): S. Vujosevic ITALY
Speakers:
Presentations:
Chairperson
13:00 Welcome and introduction
R. Gale UK
13:01 Long-term efficacy outcomes with Brolucizumab vs Aflibercept treatment in patients with early residual fluid presence in nAMD: post hoc analysis of pooled data from HAWK & HARRIER studies
J. Ehlers USA
13:05 The safety-specific, next-generation optical coherence tomography analysis from HAWK: preliminary qualitative OCT findings associated with intraocular inflammation
All Faculty
13:09 Discussion
S. Wolf SWITZERLAND
13:15 Association between visual acuity and intraretinal or subretinal fluid in patients with neovascular age-related macular degeneration treated with intravitreal aflibercept treat-and-extend: A post hoc analysis of the ARIES study
M. Gillies AUSTRALIA
13:19 Shorter treatment intervals are associated with higher treatment compliance than longer treatment intervals in a treat-and-extend regimen for nAMD
All Faculty
13:23 Discussion
R. MacLaren UK
13:29 Preliminary results from a first-in-human Phase I/II gene therapy study (FOCUS) of GT005, an investigational AAV2 vector encoding complement factor I, in patients with geographic atrophy
C. Jamison UK
13:33 Idiopathic serous epithelial detachments (SPEDs) and choroidal thickness in UK Biobank (UKBB)
All Faculty
13:37 Discussion
 
13:45 End of Session
 
See full interactive programme
The programme schedule may be subject to change. Please refer to the interactive programme for the most up to date details. 
PrevPrevious
NextNext

You might also like

Educational Debate 5: A May Double Debate! (9 May, 2022)

Read More

EURETINA Case Club: Series 1, Episode 6 with Prof Paolo Lanzetta (27 Apr, 2022)

Read More

EURETINA Session: Tumours

Read More

Secretariat Address
European Society of Retina Specialists
Ground Floor, The Apex Building 
Blackthorn Road
Sandyford Business Park
Co Dublin, D18 H6K2

Phone:+353 1 2100092
Email: [email protected]

EURETINA 2022 Hamburg

Opportunities

Memberships

Forum

About

Privacy Policy

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2021 All rights reserved
  • Events
    • Digital Events
    • EURETINA 2022 Hamburg
      • Browse Programme
      • Hotel Bookings
    • EURETINA 2021 Virtual
      • 2021 Virtual Sessions On-Demand (Members Only)
      • Programme
      • Satellite Symposia
      • Sponsors
  • Free Resources
    • Webinars
    • Podcasts
    • 2021 Virtual Session Abstracts
    • EURETINA Guidelines
    • EURETINA Brief
    • IME ePlatform
  • Membership
  • About
    • EURETINA Board
    • Subspecialty Sections
    • Bye-laws
  • Opportunities
    • Mentorship Programme 2022/23
    • RMCR grant programme
    • Observership Grant Programme
    • Women in Retina
    • YOURS
    • CME Credits
  • Member Login